These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35312027)

  • 1. Hidradenitis Suppurativa International Online Community: Patient Characteristics and a Novel Model of Treatment Effectiveness.
    Barak-Levitt J; Held R; Synett Y; Kremer N; Hodak E; Sherman S
    Acta Derm Venereol; 2022 Apr; 102():adv00686. PubMed ID: 35312027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Severity Assessment Scoring System for Hidradenitis Suppurativa.
    Hessam S; Scholl L; Sand M; Schmitz L; Reitenbach S; Bechara FG
    JAMA Dermatol; 2018 Mar; 154(3):330-335. PubMed ID: 29417136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Hidradenitis Suppurativa: A Cross-Sectional Study on Clinical Features and Treatment Approaches.
    Garcovich S; Fania L; Caposiena D; Giovanardi G; Chiricozzi A; De Simone C; Tartaglia C; Ciccone D; Bianchi L; Abeni D; Peris K
    J Cutan Med Surg; 2022; 26(2):127-134. PubMed ID: 34615396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts.
    Condamina M; Penso L; Tran VT; Hotz C; Guillem P; Villani AP; Perrot P; Bru MF; Jacquet E; Nassif A; Bachelez H; Wolkenstein P; Beylot-Barry M; Richard MA; Ravaud P; Viguier M; Sbidian E
    Dermatology; 2021; 237(5):748-758. PubMed ID: 33503635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice.
    Prens EP; Lugo-Somolinos AM; Paller AS; Kerdel F; Duan Y; Teixeira HD; Longcore M; Kimball AB
    Am J Clin Dermatol; 2020 Aug; 21(4):579-590. PubMed ID: 32077014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring Quality of Life in Hidradenitis Suppurativa: Development and Validation of a Disease-specific Patient-reported Outcome Measure for Practice and Research.
    Otten M; Augustin M; Blome C; Topp J; Niklaus M; Hilbring C; Bechara FG; Pinter A; Zouboulis CC; Anzengruber F; Kirsten N
    Acta Derm Venereol; 2023 Jan; 103():adv00859. PubMed ID: 36129249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.
    Gold DA; Reeder VJ; Mahan MG; Hamzavi IH
    J Am Acad Dermatol; 2014 Apr; 70(4):699-703. PubMed ID: 24433875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coprevalence of Hidradenitis Suppurativa and Psoriasis: Detailed Demographic, Disease Severity and Comorbidity Pattern.
    Pinter A; Sarlak M; Zeiner KN; Malisiewicz B; Kaufmann R; Romanelli M; Koenig A; Chiricozzi A
    Dermatology; 2021; 237(5):759-768. PubMed ID: 33326954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hidradenitis suppurativa in surgeons' practice: Prevalence and treatment approach according to the Hurley stage in Latvia.
    Balcere A; Upeniece I; Snipe K; Jezupovs A
    Dermatol Ther; 2021 Jan; 34(1):e14687. PubMed ID: 33331018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hidradenitis suppurativa in children: The Henry Ford experience.
    Braunberger TL; Nicholson CL; Gold L; Nahhas AF; Jacobsen G; Parks-Miller A; Hamzavi IH
    Pediatr Dermatol; 2018 May; 35(3):370-373. PubMed ID: 29575194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Characteristics and Trends in Treatment Response of Hidradenitis Suppurativa Patients: A Southern US Cohort Study.
    Peterson GC; Preston A; Frieder J; Wang X; Paek SY
    Dermatology; 2020; 236(5):413-420. PubMed ID: 31935718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain in Hidradenitis Suppurativa: A Cross-sectional Study of 1,795 Patients.
    Krajewski PK; Matusiak Ł; von Stebut E; Schultheis M; Kirschner U; Nikolakis G; Szepietowski JC
    Acta Derm Venereol; 2021 Jan; 101(1):adv00364. PubMed ID: 33320274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hidradenitis Suppurativa in Down Syndrome: A Case Series.
    Hamadah I; Haider M; Chisti M; Binamer Y
    Pediatr Dermatol; 2017 Jul; 34(4):461-464. PubMed ID: 28636122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective study of the characteristics of patients with early-onset compared to adult-onset hidradenitis suppurativa.
    Dessinioti C; Tzanetakou V; Zisimou C; Kontochristopoulos G; Antoniou C
    Int J Dermatol; 2018 Jun; 57(6):687-691. PubMed ID: 29604044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum.
    Lyons AB; Peacock A; McKenzie SA; Jacobsen G; Naik HB; Shi VY; Hamzavi IH; Hsiao JL
    JAMA Dermatol; 2020 Jun; 156(6):681-685. PubMed ID: 32347884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.
    Kimball AB; Jemec GB; Yang M; Kageleiry A; Signorovitch JE; Okun MM; Gu Y; Wang K; Mulani P; Sundaram M
    Br J Dermatol; 2014 Dec; 171(6):1434-42. PubMed ID: 25040429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with adalimumab biosimilar imraldi in hidradenitis suppurativa.
    Ricceri F; Rosi E; Di Cesare A; Pescitelli L; Fastame MT; Prignano F
    Dermatol Ther; 2020 Nov; 33(6):e14387. PubMed ID: 33030281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of Life in Hidradenitis Suppurativa: validation of the HSQoL-24.
    Marron SE; Gomez-Barrera M; Tomas Aragones L; Goni-Navarro A; Vilarrasa-Rull E; Diaz-Diaz RM; Garcia-Latasa de Aranibar FJ; Campos-Rodenas R; Fuentelsaz Del Barrio V; Gilaberte-Calzada Y; Gracia-Cazaña T; Morales-Callaghan AM; Ros-Abarca S; Madrid-Alvarez MB; Puig L
    Acta Derm Venereol; 2021 Aug; 101(8):adv00529. PubMed ID: 34427316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pain management modalities for hidradenitis suppurativa: a patient survey.
    Fernandez JM; Thompson AM; Borgstrom M; Orenstein LAV; Hsiao JL; Shi VY
    J Dermatolog Treat; 2022 May; 33(3):1742-1745. PubMed ID: 32914659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.